Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

EAST HANOVER, N.J., Dec. 2 /PRNewswire/ -- Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

The new data, at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, highlight the company's current therapies and investigational agents in 195 studies including 39 oral presentations. Data will be presented on Tasigna, Afinitor® (everolimus) tablets, Exjade® (deferasirox) and pipeline agents including PKC412 (midostaurin), LBH589 (panobinostat), BHQ880 and INCB18424, an oral, selective Janus kinase (JAK) inhibitor that was recently added to the oncology pipeline through a licensing agreement.

"Data presented at ASH will demonstrate the vigorous research underway to explore the best treatment approaches for patients with rare blood cancers and conditions," said David Epstein, President and CEO, Novartis Oncology and Novartis Molecular Diagnostics. "We expect these data to lay the groundwork for regulatory submissions and provide a roadmap for the initiation of late-stage and pivotal trials."

The ASH Annual Meeting will feature results from a pivotal head-to-head study comparing the efficacy and safety of Tasigna versus Gleevec® (imatinib mesylate) tablets(*) in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (Abstract #LBA-1; Tuesday, December 8, 2009 at 7:30 AM CST).

Data from this Phase III clinical trial, ENESTnd (Evaluating Nilotinib Efficacy and Safety in Clinical Trials of Newly Diagnosed Ph+ CML Patients), will show that Tasigna produced faster and deeper responses than Gleevec when used as first-line therapy.

Other key presentations at ASH include:


  • '/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... The Physician-Patient Alliance for Health & ... 2015, "Surviving Your Hospital Stay: Physician-Patient Alliance for ... A sentence was omitted from the ... "PPAHS is a member of the National Coalition to ... on the National Coalition to Promote Continuous Monitoring of ...
(Date:7/31/2015)... July 31, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... its previously announced underwritten public offering of 7,666,667 ... offering price of $11.25 per share. The shares ... shares issued upon the exercise in full by ...
(Date:7/31/2015)... July 31, 2015 Magnaquest, ... video, data and cloud computing operators has signed ... pharma giant for Internet of Things (IoT) related ... offered on subscription model.      (Logo: ... is striving for business innovations to make healthcare ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 11, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: ... emerging leader in the development, assembly, marketing and sale ... today announced that it will hold a conference call ... nine months ended September 30, 2010. The conference call ...
... According to Millennium Research Group (MRG), the global authority on ... CVIS market is largely a replacement market, there are key ... United Kingdom and France. In the UK, the ... Project in 2013 presents a large opportunity for radiology PACS ...
Cached Medicine Technology:Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results 2European PACS Market To Attain $512M by 2015 2
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 ... patients and family members, medical professionals, and researchers, covering a variety of topics ... is a collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... “HARMONY 2015”, one of the industry’s premier thought leadership symposiums, hosted by ... and 6. The event attracts over 250 “C”-level executives, administrators, directors of ...
(Date:7/31/2015)... ... 31, 2015 , ... The Mount Sinai Health System will work with Columbia ... of related, experimental treatments. The collaboration moves into the next phase with the recent ... of five state licenses to produce and dispense medical marijuana. , Mount Sinai ...
(Date:7/31/2015)... ... 2015 , ... Like nearly every other form of surgery, it shouldn't come ... effective and less intrusive and painful. Leading these advances in the United States ... currently stands as the only doctor in the United States who is qualified to ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased ... until a heart rate of 150 beats versus 100 beats, this is a big ... able to give life back to patients with heart disease," he adds. People with ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... Children Learning All Summer Long , ... Salt Lake City, UT (PRWEB) ... the popular Signing Time DVD series and hit public television ... communicate using American Sign Language (ASL) – is pleased to announce the ...
... of the Park Avenue Laser Vision (PALV) Center recently appeared ... a featured guest to discuss the issue of offering his ... the popular video sharing site, YouTube. Dr. Chynn explains ... a way to reach people in their 20s, 30s, and ...
... and soccer players who have had a previous concussion ... of concussion, new research released today at the 2008 ... the JW Marriott Orlando Grande Lakes shows. The study ... for significant differences in test results following the injury. ...
... the only brand,of diabetic socks available anywhere in the ... a Five Year Extended Warranty, has new owners and,is ... ) is pleased,to announce its April 1st 2008 acquisition ... to the UK via the website:, http://www.SmoothToe.co.uk ., ...
... The Pharmaceutical Care,Management Association (PCMA) released the ... which includes a provision that requires,physicians to use ... of an e-prescribing requirement in Medicare is a ... e-prescribing,is the most important issue in the Medicare ...
... Includes Three Provisions That Protect Patient Access ... The U.S. Senate,today voted by unanimous ... Medicare,Improvement for Patients and Providers Act of ... accelerated reimbursements for,Medicare Part D claims, delayed ...
Cached Medicine News:Health News:Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 3Health News:Men and women with history of concussion mend differently, study finds 2Health News:SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group 2
... A C. difficile Rapid Toxin A Test gives ... 10 minutes. When it might be C. difficile, ... that performs only a few tests a day ... for testing, ColorPAC Toxin A C. difficile Rapid ...
... aids should not suffice, then electronic magnification comes ... television set today. With an electronic television reader, ... to 70 times. A video camera shows a ... television monitor. The television reader has been especially ...
... Slit-Lamp. Rechargeable, cordless slit-lamp ... any purpose , Easy selection of ... filter , Extra-bright halogen lamp light ... and extra ,power pack , Supports ...
... Wave combines three advanced technologies - ... easy-to-use refractive diagnostic workstation. Now, with ... refraction, corneal topography, optical path difference ... Wave allows you to evaluate your ...
Medicine Products: